US Patent Issued to Takeda Pharmaceutical on March 25 for "Adeno-associated virus formulations" (Austrian, British Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,277, issued on March 25, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Adeno-associated virus formulations" was invented by Christian Fiedler (Vienna), Eva Fritscher (Vienna), Meinhard Hasslacher (Vienna), Dominik Mittergradnegger (Vienna) and Tanvir Tabish (Kent, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Adeno-associated liquid and lyophilized pharmaceutical compositions are provided herein. In exemplary aspects, the pharmaceutical compositions comprise about 5 mM to about 25 mM L-histidine, about 0 mM to about 150 mM sodium chloride, about 0.001% (w/v) to about 0.01% (w/v) polysorbate 80 (PS80), and about 1% t...